Lukas Wartman

Medicine & Life Sciences

1. Acute Myeloid Leukemia 100%
2. Acute Promyelocytic Leukemia 68%
3. Caco-2 Cells 15%
4. Chromatin Immunoprecipitation Sequencing 8%
5. Circulating Tumor DNA 9%
6. Clinical Trials 12%
7. CpG Islands 16%
8. Decision Making 10%
9. Decitabine 34%
10. Disease Progression 17%
11. Epigenomics 14%
12. Exome 11%
13. GATA2 Deficiency 36%
14. Gene Frequency 8%
15. Genes 16%
16. Genome 18%
17. Genomics 9%
18. Genotype 10%
19. Graft vs Host Disease 13%
20. Granulocyte Precursor Cells 8%
21. Hematopoietic Stem Cells 44%
22. Heterografts 11%
23. Homologous Transplantation 14%
24. Hypoxia 10%
25. Immunosuppression 12%
26. Karyotype 18%
27. Leukemia 23%
28. Lung Transplantation 15%
29. Mouth 11%
30. Mutation 69%
31. Myelodysplastic Syndromes 29%
32. Myeloid Cells 25%
33. Neoplasms 16%
34. Neuroendocrine Carcinoma 8%
35. Oncogene Fusion 8%
36. Peroxisome Proliferator-Activated Receptors 16%
37. Phenotype 11%
38. Physicians 10%
39. Protein Isoforms 10%
40. Protein Kinase C 12%
41. Pulmonary Fibrosis 10%
42. Recurrence 11%
43. Small Cell Carcinoma 8%
44. Sodium-Hydrogen Exchangers 17%
45. Squamous Cell Carcinoma 11%
46. Telomerase 15%
47. Transcription Factor AP-1 14%
48. Transplantation 14%
49. Urinary Bladder Neoplasms 12%
50. Whole Genome Sequencing 11%